Gyre Therapeutics Inc. (GYRE) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Gyre Therapeutics Inc.

    NASDAQ: GYRE · Real-Time Price · USD
    7.16
    -0.13 (-1.78%)
    At close: Sep 26, 2025, 3:59 PM
    7.50
    4.75%
    After-hours: Sep 26, 2025, 05:47 PM EDT

    Gyre Therapeutics Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 105.76M 113.45M 102.29M 7.34M
    Cost of Revenue
    		 3.88M 4.64M 798K 7.38M
    Gross Profit
    		 101.87M 108.81M 97.5M -42K
    Operating Income
    		 16.16M -67.23M 9.2M -87.89M
    Interest Income
    		 1.55M 1.04M 726K 39K
    Pretax Income
    		 23.22M -76.97M 9.41M -87.93M
    Net Income
    		 12.09M -92.93M 2.3M -87.93M
    Selling & General & Admin
    		 73.62M 75.82M 71.61M 18.82M
    Research & Development
    		 12.02M 13.78M 16.69M 68.89M
    Other Expenses
    		 66K 86.44M n/a 143K
    Operating Expenses
    		 85.71M 176.04M 88.29M 87.85M
    Interest Expense
    		 n/a n/a n/a n/a
    Selling & Marketing Expenses
    		 57.51M 61.16M 54.24M n/a
    Cost & Expenses
    		 89.59M 180.68M 93.09M 95.23M
    Income Tax Expense
    		 5.32M 8.52M 5.1M -39K
    Shares Outstanding (Basic)
    		 85.09M 65.83M 76.74M 30.64M
    Shares Outstanding (Diluted)
    		 102.29M 65.83M 75.69M 30.64M
    EPS (Basic)
    		 0.14 -1.41 0.03 -2.87
    EPS (Diluted)
    		 0.05 -1.41 0.03 -2.87
    EBITDA
    		 17.82M 20.33M 10.33M -87.6M
    EBIT
    		 16.23M 19.21M 9.2M -87.93M
    Depreciation & Amortization
    		 1.59M 1.11M 1.13M 290K

    Add to Watchlist